| 1.01 | Elect Ronald E. Blaylock - Non-Executive Director | For |
| 1.02 | Elect Albert Bourla - Chair & Chief Executive | Oppose |
| 1.03 | Elect Susan Desmond-Hellmann - Non-Executive Director | For |
| 1.04 | Elect Joseph J. Echevarria - Non-Executive Director | Oppose |
| 1.05 | Elect Scott Gottlieb - Non-Executive Director | For |
| 1.06 | Elect Helen H. Hobbs - Non-Executive Director | For |
| 1.07 | Elect Susan Hockfield - Non-Executive Director | For |
| 1.08 | Elect Dan R. Littman - Non-Executive Director | For |
| 1.09 | Elect Shantanu Narayen - Senior Independent Director | For |
| 1.10 | Elect Suzanne Nora Johnson - Non-Executive Director | For |
| 1.11 | Elect James Quincey - Non-Executive Director | For |
| 1.12 | Elect James C. Smith - Non-Executive Director | For |
| 2 | Appoint the Auditors | Oppose |
| 3 | Advisory Vote on Executive Compensation | Abstain |
| 4 | Shareholder Resolution: Proxy Access | For |
| 5 | Shareholder Resolution: Report on Political Expenditures Congruency | Oppose |
| 6 | Shareholder Resolution: Report on Transfer of Intellectual Property to Potential COVID-19 Manufacturers | For |
| 7 | Shareholder Resolution: Report on Board Oversight of Risks Related to Anticompetitive Practices | For |
| 8 | Shareholder Resolution: Public Health Costs of Protecting Vaccine Technology | For |
